Bigfoot Biomedical acquires insulin titration algorithm developed at McGill University
Bigfoot Biomedical announced today that it acquired a reinforcement learning algorithm for insulin titration from McGill University. Developers at McGill designed the algorithm to observe how well people with insulin-requiring diabetes respond to a particular dose. It provides a recommended adjustment based on the body’s response. Less than two years ago, Bigfoot Biomedical launched its Bigfoot Unity platform in some U.S. states. Last year, Brewer called it a “transformational attempt” to simplify CGMs and the data they produce to tell people how much insulin to take at a given point in time. Just last month, the company made another play to further enhance this platform. Bigfoot sold pump-based automated insulin delivery technology patents to pump maker Insulet for $25 million. This asset sale generated significant funds to expand the Bigfoot Unity diabetes management system. The company said it aims to expand access by offering Bigfoot Unity through the pharmacy channel later this year.
#insulin pen
#cgm